No studies to date have tested C-peptide in sufficiently large cohorts of patients.2, 7 Autoantibodies to the islet antigen glutamic acid decarboxylase (GAD) have been used for diagnosis, but are only present in 70% of patients with type 1 diabetes.8 This evidence concerns the gene GAD1 and type 1 diabetes mellitus.